Abstract 56: A novel B7-H6/CD3 bispecific IgG-like T cell engaging antibody for the treatment of colorectal cancer
Susanne Hipp(Technical University of Munich), Paul J. Adam(Boehringer Ingelheim (Austria)), Andrew E. Nixon, Annika Oßwald(Leibniz-Institute for Food Systems Biology at the Technical University of Munich), Craig Giragossian(Boehringer Ingelheim (Spain)), Farzaneh Sayedian(HTG Molecular Diagnostics (United States)), Christian Walterskirchen(Boehringer Ingelheim (Austria)), Manuela Kellner(HTG Molecular Diagnostics (United States)), Xiaoyun Liao(Bristol-Myers Squibb (Germany)), Aurélie Auguste(Veracyte (United States)), K. H. Bauer(Boehringer Ingelheim (Austria)), Wei Zhang(Capital Medical University), Vladimir Voynov(Boehringer Ingelheim (Spain))
Cited by 0
Related Papers
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy
|New England Journal of Medicine|2013|1.5k
A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium
|Nature Biotechnology|2014|1.1k
Aspirin Use, Tumor<i>PIK3CA</i>Mutation, and Colorectal-Cancer Survival
|New England Journal of Medicine|2012|845